Dr. Violet Zahedi’s career is a reflection of ambitious thinking and systems-level problem solving, the kind that generates breakthroughs while building the infrastructure needed to sustain them. As a physician-turned-founder, she has dedicated her career to creating ventures that challenge fragmented processes in healthcare and science, fueled by an entrepreneurial instinct that began in her childhood in Gorgan, Iran.
Zahedi began her career in medicine, where she first encountered the gap between medical discovery and real-world accessibility. Working within Iran’s healthcare system and later in clinical research roles across Europe, she observed a common pattern: that talent and ideas were abundant, but turning them into globally-impactful innovations was often slowed by systemic obstacles. Whether because of limited funding pathways, fragmented expert networks, or differences in regulatory environments, promising ideas often stalled before reaching patients.
Her first major entrepreneurial endeavor came in 2023 with the founding of Synamics Therapeutics, a Danish biotech company whose mission is to help oncology move from reactive to predictive care. Synamics applies artificial intelligence to anticipate how cancers will evolve in individual patients and design treatments aimed at staying one step ahead of those changes. The concept capitalizes on precision medicine and predictive modeling, two fields Zahedi believes will define the future of oncology.
What makes Synamics particularly notable is how quickly it gained traction. Securing funding at the concept stage (a milestone reached by less than 1% of startups), the company initiated discussions on collaborations with cancer research centers in the United States and soon relocated its headquarters to Los Angeles. As CEO, Zahedi led the company’s transition from concept to operational reality, balancing strategy, science, and global growth. But it was precisely while growing Synamics that she began to see a bigger issue. Many promising scientific ventures stalled because critical elements like capital, infrastructure, or seasoned guidance remained siloed. This realization gave her the idea for her latest venture, Xivius.
Founded in 2024 and currently preparing for launch, Xivius is an investment ecosystem designed to break down the structural barriers that prevent innovation from fully scaling. Rather than operating as a traditional fund or consulting firm, Xivius combines aspects of both into a unified platform that connects founders, investors, and industry specialists from day one. Its goal is to give visionaries access to a cohesive set of operational tools, allowing them to move forward without having to build those systems from scratch. Through this model, Xivius positions itself as a venture builder supporting companies from concept to market across a broad range of innovation, science, and technology – not just life sciences and healthcare. The idea is that by integrating these components early, companies can advance faster and with greater stability. Zahedi describes the company as a direct evolution of what she learned at Synamics; that a brilliant idea is necessary, but not sufficient. To truly change the world, ventures need systems that support execution.
As Xivius prepares for its official rollout, the company is positioning itself to support founders working across multiple sectors. Its role is envisioned as a connector of capital and also as a global bridge linking innovation hubs. Whether a project originates in Europe, Asia, or North America, Xivius aims to provide the scaffolding that allows those ideas to move seamlessly from concept to commercial and societal impact.
Zahedi’s way of thinking is influenced by her upbringing. She credits her mother with instilling a mindset built on adaptability and determination. Those values have guided her through multiple international moves, each one requiring her to quickly understand new environments and contribute meaningfully within them. They also influenced her belief that systemic thinking is important to solving some of the world’s most complex problems.
Having now made Beverly Hills her home, Zahedi sees Southern California as a world-famous community of culture and wealth. But she also views the city as fertile ground for the next generation of scientific and technological advancements. In her mind, Beverly Hills has all the requisite ingredients like capital, talent, global influence, and an entrepreneurial spirit that will help change what modern innovation looks like. Traditionally celebrated for luxury, she believes the city can also become known for forward-thinking breakthroughs that have far-reaching impact.
Zahedi argues that to shape the future, founders and investors must think architecturally, designing systems that are interconnected rather than fragmented. In her view, the next era of advancement will not be defined by producing novel discoveries, but by mastering the systems that carry those discoveries into practice. It is this commitment to big ideas and structural modernization that defines both Synamics and Xivius.
Despite her busy schedule, Dr. Zahedi remains dedicated to improving human outcomes through any means possible. Whether helping physicians anticipate how cancers evolve or giving fellow innovators the foundation to build lasting ventures, every project she takes on is measured by its potential to create scalable change. Zahedi sees Xivius as a platform for emerging founders as well as a catalyst in reshaping global innovation. By breaking down the structural bottlenecks she has encountered firsthand, she hopes to accelerate the timeline from idea to real-world implementation. In this way, Dr. Violet Zahedi is making a case for thoughtful systems-building. It is her belief that by creating the right structures today, we can enable the breakthroughs that will define tomorrow.For more information on Xivius, visit www.xivius.com.
